FDA
approval
· 2018-07-16
FDA Approved: TIMOPTIC-XE — Supplemental Application (Bausch & Lomb Incorporated)
Summary
The FDA approved a supplemental application for TIMOPTIC-XE (timolol maleate) from Bausch & Lomb Incorporated, authorizing changes to the product's existing app…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TIMOPTIC-XE (TIMOLOL MALEATE)